Skip to main content
. Author manuscript; available in PMC: 2011 Feb 7.
Published in final edited form as: Am J Clin Pathol. 1992 Jul;98(1):8–12. doi: 10.1093/ajcp/98.1.8

TABLE 5.

ER (EIA/RIBA II) Categories in Patients Listed by Frequency of Pathologic Diagnoses

Number and (%) in each ER Category
Liver Diagnosis Number of
Patients
0N +P +I +N OP OI
Cryptogenic cirrhosis 205 149 (73) 36 (18) 3 (1) 5 (2) 7 (3) 5 (2)
Primary biliary cirrhosis 178 167 (94) 4 (2) 0 (0) 5 (3) 0 (0) 2 (2)
Sclerosing cholangitis 112 100 (89) 6 (5) 1 (1) 2 (2) 2 (2) 1 (1)
Malignancy 110 93 (85) 10 (9) 1 (1) 0 (0) 4 (4) 2 (2)
Alcoholic cirrhosis 103 82 (80) 10 (10) 1 (1) 2 (2) 4 (4) 4 (4)
Cirrhosis—uncertain diagnosis 102 74 (73) 15 (15) 0 (0) 4 (4) 2 (2) 7 (7)
Chronic hepatitis B 95 63 (66) 14 (15) 4 (4) 11 (12) 0 (0) 3 (3)
Chronic NANB hepatitis 86 32 (37) 37 (43) 2 (2) 4 (5) 7 (8) 4 (5)
Acute hepatitis 49 38 (78) 3 (6) 2 (4) 5 (10) 0 (0) 1 (2)
α1 Antitrypsin deficiency 29 23 (79) 5 (17) 0 (0) 1 (3) 0 (0) 0 (0)
Budd-Chiari 20 19 (95) 1 (5) 0 (0) 0 (0) 0 (0) 0 (0)
Autoimmune hepatitis 17 13 (76) 2 (12) 0 (0) 2 (12) 0 (0) 0 (0)
Wilson’s disease 16 14 (88) 1 (6) 0 (0) 1 (6) 0 (0) 0 (0)
Miscellaneous* 60 51 (85) 4 (7) 1 (2) 2 (3) 0 (0) 2 (3)
Total 1182 918 (78) 148 (12) 15 (1) 44 (4) 26 (3) 31 (3)
*

The miscellaneous group of 60 included: secondary biliary cirrhosis (14), hemochromatosis (9), pediatric cirrhosis (6), Caroli’s disease (6), submassive hepatic necrosis (4), hemangioma (4), biliary atresia (3), congenital hepatic fibrosis (3), intrahepatic venoocchisive disease (3), cystic fibrosis (2), trauma to liver (2), chronic hepatitis (nonviral) (1), Byler’s disease (1), polycystic liver disease (1), and poisoning (1).

EIA = enzyme immunassay; NANB = non A, non B.